AstraZeneca: Q4 Earnings Insights


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


 

AstraZeneca (NASDAQ:AZN) reported its Q4 earnings results on Thursday, February 10, 2022 at 02:15 AM.

Here's what investors need to know about the announcement.

Check out this: Insiders Buy Over $43M Of 4 Stocks

Earnings

AstraZeneca beat estimated earnings by 15.07%, reporting an EPS of $0.84 versus an estimate of $0.73.

Revenue was up $4.60 billion from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08, which was followed by a 6.55% drop in the share price the next day.

Here's a look at AstraZeneca's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.62 0.43 0.75 0.68
EPS Actual 0.54 0.45 0.82 0.54
Revenue Estimate 9.87B 7.36B 7.08B 6.97B
Revenue Actual 9.87B 8.22B 7.32B 7.41B

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.


20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsBZI-Recaps